Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

立复汀 - NMPA Drug Approval Details

Approvals/NMPA/Levocabastine Hydrochloride Nasal Spray

Approved

化学药品

Levocabastine Hydrochloride Nasal Spray

Johnson & Johnson Consumer NV🇨🇳 National Medical Products Administration

Approval Date: Nov 21, 2025
Approval ID: 887Ypx8f7q8
Company: Johnson & Johnson Consumer NV
Type: 化学药品

Approval Details

Approval Id: 887Ypx8f7q8
Approval Number: 国药准字HJ20160304
Generic Name: 盐酸左卡巴斯汀鼻喷雾剂
Generic Name En: Levocabastine Hydrochloride Nasal Spray
Trade Name: 立复汀
Brand Name: 立复汀
Drug Type: 化学药品
Dosage Form: 鼻喷雾剂
Strength: 10ml:5mg(按左卡巴斯汀计),每揿含左卡巴斯汀50μg,每瓶100揿。
Reg Date: 2025-11-21
Expired Date: 2030-11-20
Company Name: Johnson & Johnson Consumer NV
Company Detail Path: /organization/johnson-and-johnson-consumer-nv

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 21, 2025

Approval ID

887Ypx8f7q8

Type

化学药品

Back to NMPA Approvals